A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT06641466 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

723

Enrollment

INDUSTRY

Sponsor class

Conditions

Menstrual Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo Comparator
DRUG: Standard of Care
DRUG: Rimegepant

Sponsor

Pfizer